You can buy or sell NGM and other stocks, options, and ETFs commission-free!
NGM Biopharmaceuticals, Inc. Common Stock, also called NGM Biopharmaceuticals, is a clinical-stage biopharmaceutical company, which engages in the discovery and development of therapeutics for cardio-metabolic, liver, oncologic, and ophthalmic diseases. Its portfolio include aldafermin (NGM282), NGM313, NGM120, NGM217, NGM621, and NGM395. The company was founded by Jin-Long Chen in 2008 and is headquartered in South San Francisco, CA. The listed name for NGM is NGM Biopharmaceuticals, Inc. Common Stock.
David J. Woodhouse
South San Francisco, California
52 Week High
52 Week Low
— per share
Expected Mar 17, After Hours